LEASE AGREEMENTLease Agreement • September 6th, 2019 • Frequency Therapeutics, Inc. • Pharmaceutical preparations
Contract Type FiledSeptember 6th, 2019 Company IndustryTHIS LEASE AGREEMENT (this “Lease”) is made this 24th day of August, 2016, between ARE-MA REGION NO. 20, LLC, a Delaware limited liability company (“Landlord”), and FREQUENCY THERAPEUTICS, INC., a Delaware corporation (“Tenant”).
LICENSE AND COLLABORATION AGREEMENT BY AND BETWEEN FREQUENCY THERAPEUTICS, INC. AND ASTELLAS PHARMA INC.License and Collaboration Agreement • September 6th, 2019 • Frequency Therapeutics, Inc. • Pharmaceutical preparations • New York
Contract Type FiledSeptember 6th, 2019 Company Industry JurisdictionTHIS LICENSE AND COLLABORATION AGREEMENT (this “Agreement”) is made and entered into as of July 16, 2019 (“Effective Date”) between Frequency Therapeutics, Inc., a corporation organized and existing under the laws of Delaware, with a principal place of business at 19 Presidential Way, Woburn, MA 01801(“Frequency”), and Astellas Pharma Inc., a corporation organized and existing under the laws of Japan, with a principal place of business at 5-1, Nihonbashi-Honcho 2-chome, Chuo-ku, Tokyo 103-8411 (“Astellas”).
NON-EXCLUSIVE PATENT LICENSE AGREEMENT MEE Agreement No: [***] MEE Case Nos: [***]Non-Exclusive Patent License Agreement • September 6th, 2019 • Frequency Therapeutics, Inc. • Pharmaceutical preparations • Massachusetts
Contract Type FiledSeptember 6th, 2019 Company Industry JurisdictionThis Non-Exclusive Patent License Agreement (“Agreement”) is made as of the 7th day of February, 2019 (“Effective Date”), by and between Frequency Therapeutics, Inc., a Delaware corporation, having a principal place of business at 19 Presidential Way, Woburn, MA 01801 (“Company”) and Massachusetts Eye and Ear Infirmary, a not-for-profit Massachusetts corporation, with a principal place of business at 243 Charles Street, Boston, Massachusetts 02114 (“Hospital”), each referred to herein individually as a “Party” and collectively as the “Parties”.